pharmaphorum
MAY 12, 2022
People who trust pharma are more interested in using the industry’s services – making building confidence in the sector key to realising the potential of patient centricity. Just 13% of people completely trust the pharma companies they interact with, 68% say the interactions feel transactional, and only a third agree that organisations know their communication preferences.
Outsourcing Pharma
MAY 12, 2022
The two companies are forming a European Medical Advisory Committee to better connect patients and physicians, inviting other trial professionals to join in.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 12, 2022
AbbVie’s Allergan subsidiary and Teva are reportedly considering making a $5 billion-plus offer to try to bring opioid liability lawsuits to a conclusion. According to a Bloomberg report , the two drugmakers are facing more than 3,500 lawsuits related to their role in fuelling the opioid crisis in the US, and have been in talks over a possible settlement for more than a year.
Outsourcing Pharma
MAY 12, 2022
Leaders from the biotech company share advice on how such organizations can make the most of often limited resources via smart strategy and collaboration.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 12, 2022
AbbVie’s would-be blockbuster Rinvoq has notched up another positive trial in Crohn’s disease, showing that it can achieve clinical remission over a full year when used as a maintenance therapy. The results of the U-ENDURE study bolster the clinical case for Rinvoq (upadacitinib), which is trying to become the first drug in the JAK inhibitor class to be approved by the FDA for Crohn’s disease with a filing due this year.
Pharma Times
MAY 12, 2022
High street service has been launched to support those experiencing symptoms potentially connected to the menopause
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Times
MAY 12, 2022
The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens
pharmaphorum
MAY 12, 2022
Bristol-Myers Squibb’s Celgene unit has clearly been impressed by progress in its four-year-old alliance with Evotec on protein degradation. It’s just paid $200 million to extend the partnership for eight more years and hiked its total value to a possible $5 billion. The two companies have been working on molecular glue degraders. These small drug compounds destabilise proteins by bringing them into proximity with enzymes called E3 ubiquitin ligases that cause them to be broken down.
pharmaphorum
MAY 12, 2022
Johnson & Johnson has appointed Thibaut Mongon as the chief executive of its consumer health division, which is scheduled to be spun off into a listed company by the end of 2023. J&J announced its intention to separate consumer health from its faster-growing prescription medicine and medical device businesses last November, creating a separate company that will be home to well-recognised brands, including Band-Aid dressings, Johnson’s baby range, Listerine mouthwash, and Tylenol pa
Expert insights. Personalized for you.
95 
Let's personalize your content